Adoptive transfer of anti-CD3-activated CD4+ T cells plus cyclophosphamide and liposome-encapsulated interleukin-2 cure murine MC-38 and 3LL tumors and establish tumor-specific immunity

Blood

Volumn 89, Issue 7, 1997, Pages 2529-2536

  Saxton, Mark L ^b   Longo, Dan L ^b   Wetzel, Holly E ^b   Tribble, Henry ^b   Alvord, W Gregory ^b   Kwak, Larry W ^b   Leonard, Arnold S ^b   Ullmann, Claudio Dansky ^b   Curti, Brendan D ^a   Ochoa, Augusto C ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; LIPOSOME; MONOCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 2;

ADOLESCENT; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; COLON ADENOCARCINOMA; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; IMMUNOLOGICAL MEMORY; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG CARCINOMA; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNITY;

EID: 0030902073     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.7.2529     Document Type: Article

References (28)

1. Ochoa AC, Hasz DE, Rezonzew R, Anderson PM, Bach FH: Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: Identification and isolation of effector subsets. Cancer Res 49:963, 1989
2. Ochoa AC, Gromo G, Alter BJ, Sondel PM, Bach FH: Long-term growth of lymphokine-activated killer (LAK) cells: Role of anti-CD3, beta-IL 1, interferon-gamma and -beta. J Immunol 138:2728, 1987
3. Loeffler CM, Platt JL, Anderson PM, Katsanis E, Ochoa JB, Urba WJ, Longo DL, Leonard AS, Ochoa AC: Antitumor effects of interleukin 2 liposomes and anti-CD3-stimulated T-cells against murine MCA-38 hepatic metastasis. Cancer Res 51:2127, 1991
4. Yun YS, Hargrove ME, Ting CC: In vivo activity of anti-CD3-induced activated killer cells. Cancer Res 49:4770, 1989
5. Anderson PM, Blazar BR, Bach FH, Ochoa AC: Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo tumor activity. J Immunol 142:1383, 1989
6. Curti BD, Longo DL, Ochoa AC, Conlon KC, Smith JW, Alvord WG, Creekmore SP, Fenton RG, Gause BL, Holmlund J, Janik JE, Ochoa J, Rice PA, Sharfman WH, Sznol M, Urba WJ: Treatment of cancer patients with ex vivo anti-CD3-activated killer cells and interleukin-2 [see comments]. J Clin Oncol 11:652, 1993
7. Thumherr N, Deschner EE, Stonehill EH, Lipkin M: Induction of adenocarcinoma in mice by weekly injections of 1,2-dimethylhydrazine. Cancer Res 33:940, 1973
8. Talmadge JE, Fidler IJ: Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. J Natl Cancer Inst 69:975, 1982
9. Bergman Y, Haimovich J: Characterization of a carcinogen-induced murine B lymphocyte cell line of C3H/eB origin. Eur J Immunol 7:413, 1977
10. Talmadge JE, Bowersox O, Tribble H, Shepard M, Liggitt D: Therapeutic and toxic activity of tumor necrosis factor is synergistic with gamma interferon. Pathol Immunopathol Res 8:21, 1989
11. LeMay LG, Kan Mitchell J, Goedegebuure P, Harel W, Mitchell MS: Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-gamma. Cancer Immunol Immunother 37:187, 1993
12. Koziol JA, Maxwell DA, Fukushima M, Colmerauer ME, Pilch YH: A distribution-free test for tumor-growth curve analyses with application to an animal tumor immunotherapy experiment. Biometrics 37:383, 1981
13. Koziol JA: VARCOV: A computer program for the distribution-free analysis of growth and response curves. Comput Methods Programs Biomed 19:69, 1984
14. Guo S, Simon R, Talmadge JE, Klabansky RL: An interactive computer program for the analysis of growth curves. Comput Biomed Res 20:37, 1987
15. SAS User's Guide. Cary, NC, SAS Institute, 1985
16. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
17. Lee ET: Statistical Methods for Survival Data Analysis. New York, NY, Wiley, 1992
18. Bookman MA, Swerdlow R, Matis LA: Adoptive chemoimmunotherapy of murine leukemia with helper T lymphocyte clones. J Immunol 139:3166, 1987
19. Yoshizawa H, Chang AE, Shu SY: Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/ interleukin 2-activated tumor-draining lymph node cells. Cancer Res 52:1129, 1992
20. Dadmarz R, Sgagias MK, Rosenberg SA, Schwartzentruber DJ: CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion. Cancer Immunol Immunother 40:1, 1995
21. Topalian SL, Rivoltini L, Mancini M, Markus NR, Robbins PF, Kawakami Y, Rosenberg SA: Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc Natl Acad Sci USA 91:9461, 1994
22. Topalian SL, Rivoltini L, Mancini M, Ng J, Hartzman RJ, Rosenberg SA: Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells. Int J Cancer 58:69, 1994
23. Mizoguchi H, O'Shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC: Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice [see comments]. Science 258:1795, 1992
24. North RJ: Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. J Exp Med 155:1063, 1982
25. Berd D, Mastrangelo MJ, Engstrom PF, Paul A, Maguire H: Augmentation of the human immune response by cyclophosphamide. Cancer Res 42:4862, 1982
26. Finke JH, Zea AH, Stanley J, Longo DL, Mizoguchi H, Tubbs RR, Wiltrout RH, O'Shea JJ, Kudoh S, Klein E, Bukowski RM, Ochoa AC: Loss of T-cell receptor zeta chain and p561ck in T-cells infiltrating human renal cell carcinoma. Cancer Res 53:5613, 1993
27. Nakagomi H, Petersson M, Magnusson I, Juhlin C, Matsuda M, Mellstedt H, Taupin JL, Vivier E, Anderson P, Kiessling R: Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res 53:5610, 1993
28. Katsanis E, Bausero MA, Ochoa AC, Loeffler CM, Blazar BR, Leonard AS, Anderson PM: Importance in timing of cyclophosphamide on the enhancement of interleukin-2-induced cytolysis. Cancer Immunol Immunother 34:74, 1991